USDA names Distinguished Senior Research Scientist of the Year
Manuel Borca's research contributed to the vaccine development for classical swine fever and African swine fever.
Page 2 of articles about vaccine in Press releases
Apiam to build new state-of-the-art viral vaccine laboratory for livestock industries
Apiam awarded grant of $700K through Victorian State Government Regional Jobs Fund to build new viral vaccine laboratory in Bendigo.
Ceva launched sow vaccine against neonatal diarrhoea with 7 antigens inside
Enteroporc Coli AC offers the broadest protection against the 7 most relevant antigens in neonatal diarrhoea in a single vaccine.
Ceva´s vaccine against pandemic swine Flu, RESPIPORC Flupan H1N1 given extra claim for sows
The extension of the claim to sows and gilts offers producers a significant economic benefit to further vaccination against flu strains.
Ceva receives positive opinion from EMA for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines
The combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age.
Boehringer Ingelheim to keep supplying U.S. foot-and-mouth disease vaccine bank
Boehringer Ingelheim will continue supplying antigen for a vaccine bank that protects U.S. livestock from a potential outbreak of foot-and-mouth disease.
Hipra: We are pleased to announce the launch of our new Hipradermic® website!
A website entirely devoted to our intradermal needle free device for swine vaccination, Hipradermic®.
New FreVAX™ smartphone application from Boehringer Ingelheim brings piglet vaccination to another level
FreVAX™ is an innovative intramuscular needle free vaccine injection device for pigs around weaning until the end of nursery. This recent development has resulted from a partnership with Henke-Sass Wolf.
Boehringer Ingelheim celebrates 25 years to combat PRRS in Europe
Boehringer Ingelheim’s PRRS vaccine celebrates 25 years of presence in Europe.
Zoetis launches CircoMax® Myco to deliver broader coverage against PCV2
Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.
Pirbright scientists will progress pig and cattle health through two projects worth €3.5 million
The research aims to tackle porcine reproductive and respiratory syndrome virus and African swine fever virus in pigs.
Cornell Alliance for Science: CRISPR offers hope for controlling African swine fever
New vaccine trials hold great promise in the management of an East African strain of African swine fever (ASF).
AASV Foundation increases research funding to $100,000; funds four proposals
The AASV Foundation increased the amount of funding available for research proposals in 2021 from $60,000 to $100,000.
Ceva and INRAE: Research and innovation in animal health
Framework agreement aimed at consolidating collaboration in animal health, the prevention of infectious diseases of animal origin, and the improvement of animal welfare.
Pharmgate: Aivlosin® WSG approved in U.S. and Canada to control Mycoplasma hyopneumoniae
This approval gives Aivlosin® WSG the broadest label indication of any product for the control of swine respiratory disease (SRD).
The Pirbright Institute: Combining aerosol and injection of a flu vaccine improves protection in pigs
Combining two different routes of administering flu vaccine provides pigs with better protection against disease than using only one method.